Markets Gone Wild

ISS and Glass Lewis Recommend Stockholders Vote “FOR” All of Catalyst’s Nominees The Incumbent Board’s Cash Distribution Plan Supported by Leading Proxy Advisory Firms Recently, leading independent proxy advisory firms ISS and Glass Lewis have recommended that stockholders of Catalyst Biosciences, Inc. vote “FOR” all of the company’s nominees. This decision comes after careful consideration…

Welcome to the Future of Retail Management Software Real Time Technologies Acquires InComm Agent Solutions August 3, 2022 Exciting news in the technology world as Real Time Technologies, Inc (RT²) has announced its acquisition of InComm Agent Solutions. This strategic move not only adds critical payments technology to RT²’s core business, but also expands serviceable…

Exploring the Smoking Accessories Market in North America A Look at the Future of Smoking Accessories Did you know that the smoking accessories market in North America is expected to see a significant increase in revenue in 2022? According to recent research, the market is projected to accumulate 38% more revenue compared to previous years….

Spain’s July Services PMI Surprises at 53.8, Beating Expectations of 52.0 – A Positive Sign for the Economy! Description: Prior 54.0Spain’s services sector continues to hold up in July, signaling another expansion with a modest rise in new business. But there are growing concerns about the outlook amid high inflation and economic uncertainty as business…

The Financial Performance of PayPal in Q2 2022 Net Revenues and Total Payment Volume Nasdaq-listed payment giant, PayPal Holdings recently reported its financial results for the second quarter of 2022 (Q2 2022). The company witnessed net revenues of $6.8 billion, which is up by almost 9% compared to the same period last year. PayPal’s total…

China Markit / Caixin Services PMI: 55.5 up from 54.5 in June Composite 54.0, prior 55.3 From the report, the summary of the Composite: “The Caixin China General Composite PMI came in at 54 in July, down 1.3 points from the previous month and still in expansionary territory. Supply and demand continued to improve with…

FDA Approves Coherus’ CIMERLI™ Introducing Coherus’ Latest FDA Approved Product Coherus Biosciences, a leading biotechnology company, has received FDA approval for their newest product, CIMERLI™. This marks Coherus’ third FDA-approved product and is the first of four new product launches planned by the end of 2023. The launch of CIMERLI™ is highly anticipated in the…

Welcome to Monroe Capital Corporation’s Second Quarter 2022 Financial Results! Financial Highlights Hey there, fellow finance enthusiasts! Today, we’re diving into the exciting world of Monroe Capital Corporation’s financial results for the second quarter of 2022. Buckle up and get ready for some numbers that will knock your socks off! Net Investment Income In the…